Alcohol withdrawal syndrome (AWS) is a medical emergency, rare in the general population, but very common among alcoholic individuals, which can lead to severe complications when unrecognized or late treated. It represents a clinical condition which can evolve in few hours or days following an abrupt cessation or reduction of alcohol intake and is characterized by hyperactivity of the autonomic nervous system resulting in the development of typical symptoms. According to DSM-5 criteria, the alcohol withdrawal syndrome is defined as such: If patients present at least two of typical signs and symptoms. The Clinical Institute Withdrawal Assessment of Alcohol Scale, revised version (CIWA-Ar), is the tool for assessing the severity of AWS. The support to patient with AWS includes pharmacological intervention as well as general support, restoration of biochemical imbalances and specific therapy. Regarding the pharmacological treatment, benzodiazepines represent the gold standard, in particular long-acting benzodiazepines, administered with a gradual reduction up to cessation.
Alcohol withdrawal syndrome: diagnostic and therapeutic methods / Perciballi, R.; Rotondo, C.; Capriglione, I.; Iannuzzi, S.; Attilia, M. L.; Coriale, G.; Vitali, M.; Ceccanti, M.; Addolorato, G.; Aliotta, V.; Alessandrini, G.; Barletta, G.; Battaglia, E.; Battagliese, G.; Carito, V.; Casciani, O.; Casella, P.; Cesarini, F.; Cibin, M.; Ciccarelli, R.; Ciolli, P.; Di Prinzio, A.; Fagetti, R.; Falconi, E.; Federico, M.; Ferraguti, G.; Fiorentino, D.; Gencarelli, S.; Giuliani, A.; Greco, A.; Intaschi, G.; Janiri, L.; La Torre, G.; Lagrutta, A.; Laviola, G.; Ledda, R.; Leggio, L.; Leonardi, C.; Loffreda, A.; Lugoboni, F.; Macri, S.; Mancinelli, R.; Marconi, M.; Maremmani, I.; Maviglia, M.; Messina, M. P.; Mistretta, M.; Montesano, F.; Pascale, E.; Parisi, M.; Pisciotta, F.; Spinnato, G.; Valchera, A.; Zavan, V.; Attilia, Fabio; Cereatti, Federica; Fiore, Marco. - In: RIVISTA DI PSICHIATRIA. - ISSN 0035-6484. - 53:3(2018), pp. 118-122. [10.1708/2925.29413]
Alcohol withdrawal syndrome: diagnostic and therapeutic methods
Perciballi R.;Rotondo C.;Capriglione I.;Iannuzzi S.;Attilia M. L.;Coriale G.;Vitali M.;Ceccanti M.;Battagliese G.;Cesarini F.;Ciccarelli R.;Ciolli P.;Ferraguti G.;Fiorentino D.;Gencarelli S.;Greco A.;La Torre G.;Ledda R.;Macri S.;Messina M. P.;Pascale E.;Pisciotta F.;Attilia, Fabio
Primo
;Cereatti, Federica;Fiore, Marco
2018
Abstract
Alcohol withdrawal syndrome (AWS) is a medical emergency, rare in the general population, but very common among alcoholic individuals, which can lead to severe complications when unrecognized or late treated. It represents a clinical condition which can evolve in few hours or days following an abrupt cessation or reduction of alcohol intake and is characterized by hyperactivity of the autonomic nervous system resulting in the development of typical symptoms. According to DSM-5 criteria, the alcohol withdrawal syndrome is defined as such: If patients present at least two of typical signs and symptoms. The Clinical Institute Withdrawal Assessment of Alcohol Scale, revised version (CIWA-Ar), is the tool for assessing the severity of AWS. The support to patient with AWS includes pharmacological intervention as well as general support, restoration of biochemical imbalances and specific therapy. Regarding the pharmacological treatment, benzodiazepines represent the gold standard, in particular long-acting benzodiazepines, administered with a gradual reduction up to cessation.| File | Dimensione | Formato | |
|---|---|---|---|
|
Attilia_alcohol-withdrawal-syndrome_2018.pdf
solo gestori archivio
Tipologia:
Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza:
Tutti i diritti riservati (All rights reserved)
Dimensione
95.4 kB
Formato
Adobe PDF
|
95.4 kB | Adobe PDF | Contatta l'autore |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
